CC
Centiva Capital Portfolio holdings
AUM
$1.51B
1-Year Return
5.86%
This Quarter Return
+1.9%
1 Year Return
+5.86%
3 Year Return
+17.07%
5 Year Return
+34.34%
10 Year Return
–
AUM
$1.98B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
-$96.8M
Cap. Flow
% of AUM
-4.9%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,695
New
585
Increased
247
Reduced
246
Closed
470
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$340M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$19.6M |
| 3 |
Apple
AAPL
|
+$18.2M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$15.6M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$15.3M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$75.7M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$48.2M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$38.1M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$30.2M |
| 5 |
IBM
IBM
|
+$21.9M |
Sector Composition
| 1 | Financials | 20.06% |
| 2 | Technology | 9.31% |
| 3 | Healthcare | 8.83% |
| 4 | Industrials | 8.07% |
| 5 | Consumer Discretionary | 5.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIGR
1076
UP Fintech Holding
TIGR
$2B
| $54.7K | ﹤0.01% |
+19,254
| New | +$54.7K |
|
1077
ThredUp
TDUP
$1.34B
| $52.9K | ﹤0.01% |
+21,673
| New | +$52.9K |
|
1078
Confluent
CFLT
$6.71B
| $51.1K | ﹤0.01% |
1,448
-10,462
| -88% | -$369K |
|
1079
Coherus Oncology, Inc. Common Stock
CHRS
$155M
| $48.3K | ﹤0.01% |
+11,300
| New | +$48.3K |
|
1080
Gilead Sciences
GILD
$146B
| $48.1K | ﹤0.01% |
624
-71,776
| -99% | -$5.53M |
|
1081
Atara Biotherapeutics
ATRA
$85.4M
| $46.9K | ﹤0.01% |
+1,166
| New | +$46.9K |
|
|
VLD
1082
DELISTED
Velo3D, Inc.
VLD
| $46.5K | ﹤0.01% |
+615
| New | +$46.5K |
|
1083
Bit Digital
BTBT
$945M
| $45.6K | ﹤0.01% |
+11,232
| New | +$45.6K |
|
1084
Caribou Biosciences
CRBU
$178M
| $45.3K | ﹤0.01% |
+10,657
| New | +$45.3K |
|
1085
Fortuna Silver Mines
FSM
$2.59B
| $44.1K | ﹤0.01% |
+13,621
| New | +$44.1K |
|
1086
Arista Networks
ANET
$192B
| $40.5K | ﹤0.01% |
+1,000
| New | +$40.5K |
|
1087
Sangamo Therapeutics
SGMO
$160M
| $39.7K | ﹤0.01% |
+30,539
| New | +$39.7K |
|
1088
Fastly
FSLY
$1.16B
| $37.6K | ﹤0.01% |
+2,387
| New | +$37.6K |
|
|
NGD
1089
New Gold Inc
NGD
$5.17B
| $37.5K | ﹤0.01% |
34,753
-68,446
| -66% | -$73.9K |
|
1090
ProQR Therapeutics
PRQR
$231M
| $37.5K | ﹤0.01% |
+23,160
| New | +$37.5K |
|
|
ENZ
1091
DELISTED
Enzo Biochem, Inc.
ENZ
| $36.1K | ﹤0.01% |
+19,610
| New | +$36.1K |
|
|
EQRX
1092
DELISTED
EQRx, Inc. Common Stock
EQRX
| $35.4K | ﹤0.01% |
+19,058
| New | +$35.4K |
|
1093
Pyxis Oncology
PYXS
$115M
| $34.7K | ﹤0.01% |
+13,546
| New | +$34.7K |
|
1094
SCYNEXIS
SCYX
$49.5M
| $33.7K | ﹤0.01% |
+11,412
| New | +$33.7K |
|
|
SVM
1095
Silvercorp Metals
SVM
$1.13B
| $33.6K | ﹤0.01% |
+11,900
| New | +$33.6K |
|
1096
Erasca
ERAS
$457M
| $33.3K | ﹤0.01% |
+12,056
| New | +$33.3K |
|
1097
Zoom
ZM
$25.4B
| $33.1K | ﹤0.01% |
+488
| New | +$33.1K |
|
|
MREO
1098
Mereo BioPharma
MREO
$290M
| $33K | ﹤0.01% |
25,000
| – | – |
|
1099
Adicet Bio
ACET
$73.4M
| $31.6K | ﹤0.01% |
12,991
-4,561
| -26% | -$11.1K |
|
|
DNMR
1100
DELISTED
Danimer Scientific, Inc.
DNMR
| $30.1K | ﹤0.01% |
+317
| New | +$30.1K |
|